Impact of Stem Cell Transplantation in Peripheral T-Cell Lymphomas
Author Information
Author(s): Peter Reimer
Primary Institution: Klinik für Hämatologie, Internistische Onkologie und Stammzelltransplantation, Kliniken Essen Süd, Evangelisches Krankenhaus Essen-Werden gGmbH
Hypothesis
What is the impact of autologous and allogeneic stem cell transplantation on the treatment outcomes of peripheral T-cell lymphomas?
Conclusion
High-dose therapy with autologous stem cell transplantation is feasible and shows promising results for patients with relapsing and refractory peripheral T-cell lymphomas.
Supporting Evidence
- High-dose therapy with autologous stem cell transplantation has shown good feasibility with low toxicity in retrospective studies.
- Achieving a complete remission at transplantation is the most important prognostic factor.
- Allogeneic stem cell transplantation has been investigated only as salvage treatment with promising results.
Takeaway
This study looks at how well stem cell transplants work for a type of cancer called peripheral T-cell lymphoma, finding that they can help many patients feel better.
Methodology
The study reviews various retrospective and prospective studies on high-dose therapy and stem cell transplantation for peripheral T-cell lymphomas.
Potential Biases
The results may be biased due to the retrospective nature of many studies and the selection of patients who proceed to transplantation.
Limitations
The study is limited by the lack of randomized trials specifically for peripheral T-cell lymphomas and the heterogeneity of the patient populations in the reviewed studies.
Participant Demographics
Most patients are older than 60 years and present with advanced stage disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website